Par Pharmaceutical Inc. drugs
2 results
Amlodipine besylate and benazepril hydrochloride (amlodipine besylate and benazepril hydrochloride)
(amlodipine besylate and benazepril hydrochloride)Par Pharmaceutical Inc.
Usage: Amlodipine besylate and benazepril hydrochloride capsules are indicated for treating hypertension in patients who do not achieve adequate control with either medication used alone.
Posaconazole (posaconazole)
(posaconazole)Par Pharmaceutical Inc.
Usage: Posaconazole delayed-release tablets are indicated for treating invasive aspergillosis in patients aged 13 and older. It also prophylaxes invasive Aspergillus and Candida infections in severely immunocompromised patients. The oral suspension is approved for treating oropharyngeal candidiasis, including cases resistant to itraconazole or fluconazole in patients 13 and older.